Aminoacetone induces oxidative modification to human plasma ceruloplasmin.
Aminoacetone (AA), a putative endogenous source of cytotoxic methylglyoxal, and ceruloplasmin (CP), the antioxidant plasma copper transporter, are known to increase in diabetes. AA was recently shown in vitro to act as a pro-oxidant toward ferritin and isolated mitochondria. We now report AA oxidative effects on CP mediated by AA-generated reactive oxygen species (ROS). Incubation of 1.5 microM human CP with 0.05-1 mM AA resulted in extensive protein aggregation. That ROS-driven thiol cross-linking underlies the CP aggregation was evidenced by the inhibitory effects of added superoxide dismutase, catalase, mannitol, and dithiothreitol. The addition of CP to AA (mM) solutions accelerated oxygen consumption by AA and caused CP copper ion release and loss of ferroxidase and aminoxidase activities. If operative in vivo, this reaction would impair the antioxidant role of CP and iron uptake by ferritin and hence contribute to intracellular iron-induced oxidative stress during AA accumulation in diabetes mellitus.
Dutra
Fernando
F
Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, CP 26077, 05513-970, São Paulo, SP, Brazil.
Ciriolo
Maria R
MR
Calabrese
Lilia
L
Bechara
Etelvino J H
EJ
D000096:Acetone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000633:toxicity*; D002570:Ceruloplasmin / Q000378:metabolism*; D006801:Humans; D007501:Iron / Q000378:metabolism; D018384:Oxidative Stress; D011765:Pyruvaldehyde / Q000633:toxicity; D017382:Reactive Oxygen Species / Q000378:metabolism
D017382:Reactive Oxygen Species; D000096:Acetone; D011765:Pyruvaldehyde; D007501:Iron; D002570:Ceruloplasmin; C006495:aminoacetone